A Legacy of Excellence.

Learn more

Bracco understands the commitment required to start, grow and maintain a successful cardiac PET program because we’ve been in the business since 1989. Tap into the expertise that more than 30 years in nuclear cardiology brings.

Cardiac PET MPI

Convenient, on-demand generator-based agent for
cardiac PET imaging

View

HeartSee™

The innovative diagnostic tool that helps you get more from your cardiac PET imaging

View

Why Bracco?

Committed to excellence in cardiac PET for almost 30 years

View

“This is a test that one gets and gets an answer.”

Dr. Craig WalkerInterventional Cardiologist, Founder and President, Cardiovascular Institute of the South

“There are no clinical scenarios where PET should not be considered a preferred test for patients who meet appropriate criteria for a stress imaging test and who require pharmacologic stress.”1

ASNC/SNMMI Position Statement(Click here for full position statement)

Subscribe to receive exclusive resources and important updates from Bracco.

Our success is your success.

Bracco continues to advance our technology and service to deliver the best solutions in cardiac PET imaging.

  • Safe, efficient cardiac PET MPI offers diagnostic
    confidence2-4
  • Convenient for patients and clinicians
  • Enhanced patient management for your busy practice

See what the experts have to say.

See what the experts and patients of Cardiovascular Institute of the South in Houma, Louisiana have to say about the benefits of cardiac PET.

CardioGen-82 Full Prescribing Information

Find Your Representative

Simply enter your zip code below, and you can contact your Bracco representative directly.

GO
Generic filters
Exact matches only

Indications and Usage:
IMPORTANT SAFETY INFORMATION:

Indications and Usage:
CARDIOGEN-82® (Rubidium Rb 82 Generator) is a closed system used to produce rubidium Rb 82 chloride injection for intravenous administration. Rubidium Rb 82 chloride injection is a radioactive diagnostic agent indicated for Positron Emission Tomography (PET) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease.

IMPORTANT SAFETY INFORMATION:

Indications and Usage:
CARDIOGEN-82® (Rubidium Rb 82 Generator) is a closed system used to produce rubidium Rb 82 chloride injection for intravenous administration. Rubidium Rb 82 chloride injection is a radioactive diagnostic agent indicated for Positron Emission Tomography (PET) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease.

IMPORTANT SAFETY INFORMATION:

WARNING: HIGH LEVEL RADIATION EXPOSURE WITH USE OF INCORRECT ELUENT AND FAILURE TO FOLLOWTHE ELUATE TESTING PROTOCOL
Please see full prescribing information for complete boxed warning

High Level Radiation Exposure with Use of Incorrect Eluent
Using the incorrect eluent can cause high Strontium (Sr) 82 and Sr 85 breakthrough levels (5.1)

  • Use only additive-free 0.9%Sodium Chloride Injection USP to elute the generator (2.5)
  • Immediately stop the patient infusion and permanently discontinue the use of the affected CARDIOGEN-82® generator if the incorrect solution is used to elute the generator (4)
  • Evaluate the patient’s radiation absorbed dose and monitor for the effects of radiation to critical organs such as bone marrow (2.10)

Excess Radiation Exposure with Failure to Follow the Eluate Testing Protocol
Excess radiation exposure occurs when the levels of Sr 82 or Sr 85 in the rubidium Rb 82 chloride injection exceed limits. (5.2)

  • Record eluate volume, including waste and test volumes. (2.5)
  • Strictly adhere to the generator eluate testing protocol (2.6, 2.7)
  • Stop using the generator if it reaches any of its Expiration Limits (2.8)

Please see full Prescribing Information for CARDIOGEN-82® (Rubidium Rb 82 Generator) including boxed WARNING at https://imaging.bracco.com/us-en/products/nuclear-medicine-radiopharmaceuticals/cardiogen-82/.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

REFERENCES:

  1. Bateman TM, Dilsizian V, Beanlands RS, et al. American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging Joint Position Statement on the Clinical Indications for Myocardial Perfusion PET. J Nucl Med. 2016; 57(10):1654-1656
  2. Cardiogen-82 (Rubidium Rb 82 Generator) for Positron Emission Tomography Myocardial Perfusion Imaging, full Prescribing Information. Monroe Twp, NJ: Bracco Diagnostics Inc. October 2020.
  3. Kiran R. Nandalur, MD, Ben A. Dwamena, MD, Asim F. Choudhri, MD, Sirisha R. Nandalur, MD, Priya Reddy, Ruth C. Carlos, MD. Diagnostic Performance of Positron Emission Tomography in the Detection of Coronary Artery Disease: A Meta-analysis. Academic Radiology, Vol 15, No 4, April 2008.
  4. Brian A. Mc Ardle, MB, BCH, Taylor F. Dowsley, MD, Robert A. deKemp, PHD, George A. Wells, PHD, Rob S. Beanlands, MD. Does Rubidium-82 PET Have Superior Accuracy to SPECT Perfusion Imaging for the Diagnosis of Obstructive Coronary Disease? JACC. Vol. 60, No. 18, 2012.

CARDIOGEN-82 is manufactured for Bracco Diagnostics Inc., Monroe Township, NJ 08831, by GE Healthcare, Medi-Physics, Inc., South Plainfield, NJ 07080.

CARDIOGEN-82 is a registered trademark of Bracco Diagnostics Inc.

WE ARE CARDIAC PET is a trademark of Bracco Diagnostics Inc.